Extradural motor cortex stimulation in Parkinson's sisease

Roberto Cilia, Andrea Landi, Francesco Vergani, Erik Sganzerla, Gianni Pezzoli, Angelo Antonini

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Extradural motor cortex stimulation (EMCS) is a surgical procedure proposed for patients with advanced Parkinson's disease (PD) who cannot undergo deep brain stimulation (DBS). Five PD patients with motor fluctuations and dyskinesia underwent EMCS of the left hemisphere. All fulfilled CAPSIT criteria for DBS, with the exception of age > 70 years. Patients were assessed preoperatively and 6 months after surgery on and off medications, with stimulator on, and 2 weeks later with stimulator off. Outcome measures included changes in mean medication dosage (levodopa and dopamine agonists), Unified Parkinson's Disease Rating Scale (UPDRS Parts II-III and Item 39), and dyskinesias (Abnormal Involuntary Movements Scale [AIMS]). We found no significant mean changes following EMCS. However, there was a trend for a reduction of mean daily medication intake (-30%) and AIMS (-19%). There were 3 patients who reported reduced OFF time (UPDRS Item 39) and 4 of 5 who felt a subjective benefit in stability and gait. In our PD cohort, EMCS induced no objective benefit, although some subjective improvement was reported mostly on axial symptoms.

Original languageEnglish
Pages (from-to)111-114
Number of pages4
JournalMovement Disorders
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Motor Cortex
Parkinson Disease
Deep Brain Stimulation
Dyskinesias
Dopamine Agonists
Levodopa
Gait
Outcome Assessment (Health Care)
Abnormal Involuntary Movement Scale

Keywords

  • Extradural motor cortex stimulation
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Cilia, R., Landi, A., Vergani, F., Sganzerla, E., Pezzoli, G., & Antonini, A. (2007). Extradural motor cortex stimulation in Parkinson's sisease. Movement Disorders, 22(1), 111-114. https://doi.org/10.1002/mds.21207

Extradural motor cortex stimulation in Parkinson's sisease. / Cilia, Roberto; Landi, Andrea; Vergani, Francesco; Sganzerla, Erik; Pezzoli, Gianni; Antonini, Angelo.

In: Movement Disorders, Vol. 22, No. 1, 01.2007, p. 111-114.

Research output: Contribution to journalArticle

Cilia, R, Landi, A, Vergani, F, Sganzerla, E, Pezzoli, G & Antonini, A 2007, 'Extradural motor cortex stimulation in Parkinson's sisease', Movement Disorders, vol. 22, no. 1, pp. 111-114. https://doi.org/10.1002/mds.21207
Cilia R, Landi A, Vergani F, Sganzerla E, Pezzoli G, Antonini A. Extradural motor cortex stimulation in Parkinson's sisease. Movement Disorders. 2007 Jan;22(1):111-114. https://doi.org/10.1002/mds.21207
Cilia, Roberto ; Landi, Andrea ; Vergani, Francesco ; Sganzerla, Erik ; Pezzoli, Gianni ; Antonini, Angelo. / Extradural motor cortex stimulation in Parkinson's sisease. In: Movement Disorders. 2007 ; Vol. 22, No. 1. pp. 111-114.
@article{a08679166ca24807b10089ce0f9bb2f3,
title = "Extradural motor cortex stimulation in Parkinson's sisease",
abstract = "Extradural motor cortex stimulation (EMCS) is a surgical procedure proposed for patients with advanced Parkinson's disease (PD) who cannot undergo deep brain stimulation (DBS). Five PD patients with motor fluctuations and dyskinesia underwent EMCS of the left hemisphere. All fulfilled CAPSIT criteria for DBS, with the exception of age > 70 years. Patients were assessed preoperatively and 6 months after surgery on and off medications, with stimulator on, and 2 weeks later with stimulator off. Outcome measures included changes in mean medication dosage (levodopa and dopamine agonists), Unified Parkinson's Disease Rating Scale (UPDRS Parts II-III and Item 39), and dyskinesias (Abnormal Involuntary Movements Scale [AIMS]). We found no significant mean changes following EMCS. However, there was a trend for a reduction of mean daily medication intake (-30{\%}) and AIMS (-19{\%}). There were 3 patients who reported reduced OFF time (UPDRS Item 39) and 4 of 5 who felt a subjective benefit in stability and gait. In our PD cohort, EMCS induced no objective benefit, although some subjective improvement was reported mostly on axial symptoms.",
keywords = "Extradural motor cortex stimulation, Parkinson's disease",
author = "Roberto Cilia and Andrea Landi and Francesco Vergani and Erik Sganzerla and Gianni Pezzoli and Angelo Antonini",
year = "2007",
month = "1",
doi = "10.1002/mds.21207",
language = "English",
volume = "22",
pages = "111--114",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Extradural motor cortex stimulation in Parkinson's sisease

AU - Cilia, Roberto

AU - Landi, Andrea

AU - Vergani, Francesco

AU - Sganzerla, Erik

AU - Pezzoli, Gianni

AU - Antonini, Angelo

PY - 2007/1

Y1 - 2007/1

N2 - Extradural motor cortex stimulation (EMCS) is a surgical procedure proposed for patients with advanced Parkinson's disease (PD) who cannot undergo deep brain stimulation (DBS). Five PD patients with motor fluctuations and dyskinesia underwent EMCS of the left hemisphere. All fulfilled CAPSIT criteria for DBS, with the exception of age > 70 years. Patients were assessed preoperatively and 6 months after surgery on and off medications, with stimulator on, and 2 weeks later with stimulator off. Outcome measures included changes in mean medication dosage (levodopa and dopamine agonists), Unified Parkinson's Disease Rating Scale (UPDRS Parts II-III and Item 39), and dyskinesias (Abnormal Involuntary Movements Scale [AIMS]). We found no significant mean changes following EMCS. However, there was a trend for a reduction of mean daily medication intake (-30%) and AIMS (-19%). There were 3 patients who reported reduced OFF time (UPDRS Item 39) and 4 of 5 who felt a subjective benefit in stability and gait. In our PD cohort, EMCS induced no objective benefit, although some subjective improvement was reported mostly on axial symptoms.

AB - Extradural motor cortex stimulation (EMCS) is a surgical procedure proposed for patients with advanced Parkinson's disease (PD) who cannot undergo deep brain stimulation (DBS). Five PD patients with motor fluctuations and dyskinesia underwent EMCS of the left hemisphere. All fulfilled CAPSIT criteria for DBS, with the exception of age > 70 years. Patients were assessed preoperatively and 6 months after surgery on and off medications, with stimulator on, and 2 weeks later with stimulator off. Outcome measures included changes in mean medication dosage (levodopa and dopamine agonists), Unified Parkinson's Disease Rating Scale (UPDRS Parts II-III and Item 39), and dyskinesias (Abnormal Involuntary Movements Scale [AIMS]). We found no significant mean changes following EMCS. However, there was a trend for a reduction of mean daily medication intake (-30%) and AIMS (-19%). There were 3 patients who reported reduced OFF time (UPDRS Item 39) and 4 of 5 who felt a subjective benefit in stability and gait. In our PD cohort, EMCS induced no objective benefit, although some subjective improvement was reported mostly on axial symptoms.

KW - Extradural motor cortex stimulation

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=33847693879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847693879&partnerID=8YFLogxK

U2 - 10.1002/mds.21207

DO - 10.1002/mds.21207

M3 - Article

C2 - 17083104

AN - SCOPUS:33847693879

VL - 22

SP - 111

EP - 114

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 1

ER -